Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

ABEO / Abeona Therapeutics Inc. / PERCEPTIVE ADVISORS LLC - AMENDMENT NO. 3 TO SCHEDULE 13G (Passive Investment)

2018-02-16 sec.gov
Amendment No. 3 to Schedule 13G     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)*     Abeona Therapeutics, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 00289Y 10 7 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-

ABEO / Abeona Therapeutics Inc. / Knoll Capital Management, LP - SC 13G/A (Passive Investment)

2018-02-16 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G* (Rule 13d-102)   INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Amendment No. 2)   Abeona Therapeutics, Inc   (Name of Issuer)   Common Stock, $0.01 par value per share   (Title of Class of Securities)   0289Y107   (CUSIP Number)   December 31, 2017   (Date of Event Which Requires Filing of the Statement)   Che

ABEO / Abeona Therapeutics Inc. / Viking Global Investors LP - 3G/A (Passive Investment)

2018-02-16 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ Schedule 13G/A ________________ INFORMATION TO BE INCLUDED IN STATEMENTS PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934* (Amendment No. 1) Abeona Therapeutics Inc. (Name of Issuer) Common stock (Title of Class of Securities) 00289Y107 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriat

ABEO / Abeona Therapeutics Inc. / Knoll Capital Management, LP - SC 13G/A (Passive Investment)

2018-02-15 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G* (Rule 13d-102)   INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Amendment No. 2)   Abeona Therapeutics, Inc   (Name of Issuer)   Common Stock, $0.01 par value per share   (Title of Class of Securities)   0289Y107   (CUSIP Number)   December 31, 2017   (Date of Event Which Requires Filing of the Statement)   Che

ABEO / Abeona Therapeutics Inc. / PERCEPTIVE ADVISORS LLC - AMENDMENT NO. 3 TO SCHEDULE 13G (Passive Investment)

2018-02-15 sec.gov
Amendment No. 3 to Schedule 13G     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)*     Abeona Therapeutics, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 00289Y 10 7 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-

ABEO / Abeona Therapeutics Inc. / Viking Global Investors LP - 3G/A (Passive Investment)

2018-02-15 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ Schedule 13G/A ________________ INFORMATION TO BE INCLUDED IN STATEMENTS PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934* (Amendment No. 1) Abeona Therapeutics Inc. (Name of Issuer) Common stock (Title of Class of Securities) 00289Y107 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriat

ABEO / Abeona Therapeutics Inc. / Adage Capital Partners GP LLC - ABEONA THERAPEUTICS INC. (Passive Investment)

2018-02-14 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G/A   Under the Securities Exchange Act of 1934 (Amendment No. 1)*   Abeona Therapeutics Inc. (Name of Issuer)   Common Stock, $0.01 par value (Title of Class of Securities)   00289Y107 (CUSIP Number)   December 31, 2017 and January 29, 2018** (Date of Event Which Requires Filing of This Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   ¨ Rule 13d-1(b) ý Rule 13d-1(c) ¨

ABEO / Abeona Therapeutics Inc. / Adage Capital Partners GP LLC - ABEONA THERAPEUTICS INC. (Passive Investment)

2018-02-14 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G/A   Under the Securities Exchange Act of 1934 (Amendment No. 1)*   Abeona Therapeutics Inc. (Name of Issuer)   Common Stock, $0.01 par value (Title of Class of Securities)   00289Y107 (CUSIP Number)   December 31, 2017 and January 29, 2018** (Date of Event Which Requires Filing of This Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   ¨ Rule 13d-1(b) ý Rule 13d-1(c) ¨

ROTY Edition 1 Volume 78: Simplify Your Decision-Making And Stick To Guidelines

2018-02-13 seekingalpha
As always, readers are encouraged to do their own due diligence, manage risk appropriately, and avoid blindly following. (313-2)

ABEO / Abeona Therapeutics Inc. - Stock Institutional Ownership and Shareholders - Fintel.io

2018-02-13 fintel.io
Abeona Therapeutics Inc. (NASDAQ:ABEO) has 104 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 18,766,711 shares. Largest shareholders include Knoll Capital Management, LP, Viking Global Investors LP, Adage Capital Partners GP LLC, BlackRock Inc., Baker Brothers Advisors LP, Castle Hook Partners LP, Vanguard Group Inc, Susquehanna International Group, Llp, Highbridge Capital Management Llc, and Castle Hook Partners LP. (64-1)

ABEO / Abeona Therapeutics Inc. / FMR LLC / Fidelity - 3G (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 0 ABEONA THERAPEUTICS INC COMMON STOCK Cusip #00289Y107 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #00289Y107 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 60,000 Item 6: 0 Item 7: 3,903,591 Item 8: 0 Item 9: 3,903,591 Item 11: 8.

ABEO / Abeona Therapeutics Inc. / FMR LLC / Fidelity - 3G (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 0 ABEONA THERAPEUTICS INC COMMON STOCK Cusip #00289Y107 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #00289Y107 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 60,000 Item 6: 0 Item 7: 3,903,591 Item 8: 0 Item 9: 3,903,591 Item 11: 8.

Abeona Therapeutics: Data Update - Part 2

2018-02-12 seekingalpha
I remind readers to read my still-available prior update piece for a recap of the bullish thesis and financial snapshot. (34-1)

ABEO / Abeona Therapeutics Inc. FORM 8-K (Current Report)

2018-02-09 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of report (Date of earliest event reported): February 9, 2018   ABEONA THERAPEUTICS INC. (Exact name of registrant as specified in its charter)   Delaware 001-15771 83-0221517 (State or other jurisdiction of incorporation) (Commission File Number) (I.

ROTY Edition 1 Volume 77: Market Turmoil Continues - How To React

2018-02-09 seekingalpha
Recent market volatility is addressed and we discuss in depth how to react while sticking to one´s plan. (192-1)


CUSIP: 00289Y115